Literature DB >> 11043152

Behaviour in early treated phenylketonuria: a systematic review.

I Smith1, J Knowles.   

Abstract

UNLABELLED: A search was made of the literature on behaviour in early treated phenylketonuria (PKU). Some 34 publications were selected for systematic review in order to answer the following questions: (1) does behaviour in early treated subjects with PKU differ from that in the general population?, (2) if so, do the differences show any consistent pattern?, matter in real life?, relate to intellectual status, phenylalanine (Phe) control or social factors? and (3) can behavioural problems be precipitated or reversed by changes in Phe control?. Eleven reports based on four studies of > 20 subjects provided the most useful data. There was good evidence of differences between subjects with PKU and their unaffected peers in behaviour and perception of self. The pattern of results was consistent across nations and age groups (higher scores on emotional/neurotic items and lower scores on anti-social/aggressive items) and suggested that subjects with PKU are more prone to depression, anxiety, phobic tendencies, isolation from their peers and a less "masculine" self image. Features of attention deficit hyperactivity disorder and associations between behaviour problems and both lower IQ and a worse quality of Phe control were well documented in several studies.
CONCLUSION: The literature did not allow for definite conclusions on the cause of the behavioural problems but, taken together, the findings suggest that both the stressful dietary intervention and a degree of neurobiological impairment are likely to play a part.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043152     DOI: 10.1007/pl00014392

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Authors:  Emma Medford; Dougal Julian Hare; Anja Wittkowski
Journal:  JIMD Rep       Date:  2017-08-25

3.  Effects of dietary management of phenylketonuria on long-term cognitive outcome.

Authors:  Shelley Channon; Galya Goodman; Sally Zlotowitz; Caroline Mockler; Philip J Lee
Journal:  Arch Dis Child       Date:  2006-10-26       Impact factor: 3.791

Review 4.  Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management.

Authors:  Suzanne W Boyer; Lisa J Barclay; Lindsay C Burrage
Journal:  Nutr Clin Pract       Date:  2015-06-16       Impact factor: 3.080

5.  Parenting a Child with Phenylketonuria: An Investigation into the Factors That Contribute to Parental Distress.

Authors:  Olivia Ambler; Emma Medford; Dougal J Hare
Journal:  JIMD Rep       Date:  2018-04-20

6.  Cognitive functioning and psychiatric disorders in children with a metabolic disease.

Authors:  Annik Simons; François Eyskens; Ann De Groof; Ellen Van Diest; Dirk Deboutte; Robert Vermeiren
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-03-10       Impact factor: 4.785

7.  Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria.

Authors:  G L Arnold; C J Vladutiu; C C Orlowski; E M Blakely; J DeLuca
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 8.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

Review 9.  Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?

Authors:  F J van Spronsen; Marieke Hoeksma; Dirk-Jan Reijngoud
Journal:  J Inherit Metab Dis       Date:  2009-01-13       Impact factor: 4.982

10.  Phenylketonuria: nutritional advances and challenges.

Authors:  Marcello Giovannini; Elvira Verduci; Elisabetta Salvatici; Sabrina Paci; Enrica Riva
Journal:  Nutr Metab (Lond)       Date:  2012-02-03       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.